Free treatment for those who have been seriously infected by Covid, this is the proposal put forward by Minister Speranza; meanwhile, the pandemic in Italy continues to record a slow decline in the contagion curve. “Coronavirus can leave, in patients who have had it in severe form, consequences even after recovery. That is why I have proposed that they be allocated 50 million euro so that the National Health Service takes care of all the patients most affected by the virus free of charge, with diagnostic tests and therapies. Even after discharge from the hospital. This measure will also allow us to start monitoring to acquire further data to be made available to our researchers ". This was stated on health minister Roberto Speranza.
Meanwhile, the pandemic emergency continues to be monitored and studied by qualified teams of experts. According to ministerial sources, in the last 24 hours in Italy they have registered 10.176 new positive cases (yesterday 10.554). The new deaths are 224 (yesterday 207). In the intensive care units they are hospitalized 2211 Covid patients (2253 yesterday), while in home isolation they still remain 372.110 people infected with the virus (378.890 yesterday). The carried out molecular and antigenic buffers are 338.436 (yesterday 328.612). The discharged healed today are 17.394 (yesterday 15.580); altogether the positive cases are 390.120, 7444 cheaper than yesterday.
Free treatment for 50 million euros
The intention is to allocate approximately 19 million euros to the follow-up of Covid-50 patients until 2023, which should be divided into over 24 million euros for the current year. And about 20 million for 2022 and just under 6 million for 2023. “Resources - underlines the ministry explaining the proposal - which will be used for the 'National experimental monitoring protocol'. The protocol provides for the provision, free of charge, of outpatient specialist services falling within the essential levels of assistance ".
This, based on the severity of the patient's symptoms for monitoring, the prevention and early diagnosis of any outcomes or complications. Therefore, treatments for people who over time could report chronic effects following a Covid-19 disease with a severe clinical picture. Subjects often elderly, which could have cardiac and pulmonary consequences and in which it is essential to identify early the development of pulmonary fibrosis or heart disease ".
Moderna and Sputnik, the latest news on the two vaccines
A booster dose of the Covid-19 vaccine of Modern generated a promising immune response against the most dangerous variants of Sars-Cov2, the Brazilian and the South African. This was stated in a note by the manufacturer, citing the first results of an ongoing clinical study, with which Moderna is testing a booster dose of 50 micrograms in individuals already vaccinated. The results show that this increased neutralizing antibody responses against the original virus as well as against variant B.1.351 and P.1 identified in South Africa and Brazil.
The company points out that the booster doses were "generally well tolerated". Meanwhile, the single-dose version of the Sputnik V vaccine, called Sputnik Light, was registered in Russia. The Russian Fund for Direct Investments (Ref) in a note. The single-dose vaccine Sputnik Light demonstrated 79,4 percent efficacy according to data analyzed, as part of the Russian mass vaccination program, between December 5, 2020 and April 15, 2021.
